A relaxin-based nanotherapy for liver fibrosis

被引:11
作者
Fallowfield, Jonathan A. [1 ]
Ramachandran, Prakash [1 ]
机构
[1] Univ Edinburgh, Queens Med Res Inst, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland
基金
英国医学研究理事会;
关键词
D O I
10.1038/s41565-020-00832-w
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Targeting of the peptide hormone relaxin to injured mouse liver, via a nanoparticle/gene therapy approach, switches pro-fibrotic hepatic macrophages to a restorative phenotype that orchestrates tissue repair.
引用
收藏
页码:365 / 366
页数:2
相关论文
共 12 条
[1]   Relaxin decreases the severity of established hepatic fibrosis in mice [J].
Bennett, Robert G. ;
Heimann, Dean G. ;
Singh, Sudhir ;
Simpson, Ronda L. ;
Tuma, Dean J. .
LIVER INTERNATIONAL, 2014, 34 (03) :416-426
[2]   Relaxin abrogates renal interstitial fibrosis by regulating macrophage polarization via inhibition of Toll-like receptor 4 signaling [J].
Chen, Lei ;
Sha, Ming-Lei ;
Li, Deng ;
Zhu, Yi-Ping ;
Wang, Xing-Jie ;
Jiang, Chen-Yi ;
Xia, Shu-Jie ;
Shao, Yi .
ONCOTARGET, 2017, 8 (13) :21044-21053
[3]   Relaxin Modulates Human and Rat Hepatic Myofibroblast Function and Ameliorates Portal Hypertension In Vivo [J].
Fallowfield, Jonathan A. ;
Hayden, Annette L. ;
Snowdon, Victoria K. ;
Aucott, Rebecca L. ;
Stutchfield, Ben M. ;
Mole, Damian J. ;
Pellicoro, Antonella ;
Gordon-Walker, Timothy T. ;
Henke, Alexander ;
Schrader, Joerg ;
Trivedi, Palak J. ;
Princivalle, Marc ;
Forbes, Stuart J. ;
Collins, Jane E. ;
Iredale, John P. .
HEPATOLOGY, 2014, 59 (04) :1492-1504
[4]   Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis [J].
Hu, Mengying ;
Wang, Ying ;
Liu, Zhengsheng ;
Yu, Zhuo ;
Guan, Kaiyun ;
Liu, Mengrui ;
Wang, Menglin ;
Tan, Jun ;
Huang, Leaf .
NATURE NANOTECHNOLOGY, 2021, 16 (04) :466-+
[5]   Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis [J].
Kaftanovskaya, Elena M. ;
Ng, Hooi Hooi ;
Soula, Mariluz ;
Rivas, Bryan ;
Myhr, Courtney ;
Ho, Brian A. ;
Cervantes, Briana A. ;
Shupe, Thomas D. ;
Devarasetty, Mahesh ;
Hu, Xin ;
Xu, Xin ;
Patnaik, Samarjit ;
Wilson, Kenneth J. ;
Barnaeva, Elena ;
Ferrer, Marc ;
Southall, Noel T. ;
Marugan, Juan J. ;
Bishop, Colin E. ;
Agoulnik, Irina U. ;
Agoulnik, Alexander I. .
FASEB JOURNAL, 2019, 33 (11) :12435-12446
[6]   A single adenovirus-mediated relaxin delivery attenuates established liver fibrosis in rats [J].
Kim, Ja Kyung ;
Lee, Jung Il ;
Paik, Yong-Han ;
Yun, Chae-Ok ;
Chang, Hye Young ;
Lee, Su Yeon ;
Lee, Kwan Sik .
JOURNAL OF GENE MEDICINE, 2016, 18 (1-3) :16-26
[7]   Human relaxin-2 attenuates hepatic steatosis and fibrosis in mice with non-alcoholic fatty liver disease [J].
Lee, Kuei-Chuan ;
Hsieh, Yun-Cheng ;
Chan, Che-Chang ;
Sun, Hao-Jhe ;
Huang, Yi-Hsiang ;
Hou, Ming-Chih ;
Lin, Han-Chieh .
LABORATORY INVESTIGATION, 2019, 99 (08) :1203-1216
[8]   Engineered Relaxin as theranostic nanomedicine to diagnose and ameliorate liver cirrhosis [J].
Nagorniewicz, Beata ;
Mardhian, Deby F. ;
Booijink, Richell ;
Storm, Gert ;
Prakash, Jai ;
Bansal, Ruchi .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2019, 17 :106-118
[9]   Liver fibrosis and repair: immune regulation of wound healing in a solid organ [J].
Pellicoro, Antonella ;
Ramachandran, Prakash ;
Iredale, John P. ;
Fallowfield, Jonathan A. .
NATURE REVIEWS IMMUNOLOGY, 2014, 14 (03) :181-194
[10]   Resolving the fibrotic niche of human liver cirrhosis at single-cell level [J].
Ramachandran, P. ;
Dobie, R. ;
Wilson-Kanamori, J. R. ;
Dora, E. F. ;
Henderson, B. E. P. ;
Luu, N. T. ;
Portman, J. R. ;
Matchett, K. P. ;
Brice, M. ;
Marwick, J. A. ;
Taylor, R. S. ;
Efremova, M. ;
Vento-Tormo, R. ;
Carragher, N. O. ;
Kendall, T. J. ;
Fallowfield, J. A. ;
Harrison, E. M. ;
Mole, D. J. ;
Wigmore, S. J. ;
Newsome, P. N. ;
Weston, C. J. ;
Iredale, J. P. ;
Tacke, F. ;
Pollard, J. W. ;
Ponting, C. P. ;
Marioni, J. C. ;
Teichmann, S. A. ;
Henderson, N. C. .
NATURE, 2019, 575 (7783) :512-+